Scilex Holding Company Announces Receipt of Notice from Nasdaq – Stock Titan

SP-103 has been granted Fast Track status from the FDA in low back pain; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release …
Source: back pain

Leave a Reply

Your email address will not be published. Required fields are marked *